Coinfections with HIV-1 and HTLV-I or HTLV-II have been associated with unique
immunophenotypes and an increased risk for development of neurodegenerative …

The finding of dual HTLV-I and HIV-1 infection in populations at risk for AIDS raises the
possibility that interaction between the two viruses might have clinical significance. It was …

To determine whether coinfection with HTLV-II influences the course of HIV-1 infection, we
evaluated the progression from asymptomatic HIV infection (CDC group II) to persistent …

Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

Objectives: To determine the seroprevalence of, and risk factors for, HTLV-I and HTLV-II
infection among HIV-infected women and women at high risk for HIV infection. Design …

In the last 10 years HIV-1/human T-cell leukemia virus (HIV-1/HTLV) coinfection has
emerged as a worldwide health problem. The numbers of HIV-1/HTLV-1 coinfections in …

HTLV-I and HTLV-II infect T lymphocytes. A high HTLV-I proviral load in peripheral blood
mononuclear cells (PBMCs) has been associated with a higher risk of neurologic disease …

Co‐infections with HIV‐1 and the human T leukemia virus types 1 and 2 (HTLV‐1, HTLV‐2)
occur frequently, particularly in large metropolitan areas where injection drug use is a …

Co-infection with HTLV-1 reaches 20% among patients infected by HIV-1 in Bahia, Brazil. To
evaluate its impact on survival, we conducted a retrospective, case–control study involving …